Eastman Chemical (EMN)
(Delayed Data from NYSE)
$110.33 USD
-0.25 (-0.23%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $110.38 +0.05 (0.05%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Income Statements
Fiscal Year end for Eastman Chemical Company falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9,210 | 10,580 | 10,476 | 8,473 | 9,273 |
Cost Of Goods | 7,149 | 8,443 | 7,976 | 6,498 | 7,039 |
Gross Profit | 2,061 | 2,137 | 2,500 | 1,975 | 2,234 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,003 | 1,036 | 1,631 | 1,115 | 1,054 |
Income After Depreciation & Amortization | 1,058 | 1,101 | 869 | 860 | 1,180 |
Non-Operating Income | 326 | -144 | -413 | 118 | 60 |
Interest Expense | 215 | 182 | 198 | 210 | 218 |
Pretax Income | 1,087 | 977 | 1,082 | 530 | 902 |
Income Taxes | 191 | 181 | 215 | 41 | 140 |
Minority Interest | 2 | 3 | 10 | 11 | 3 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 896 | 796 | 867 | 489 | 762 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 894 | 793 | 857 | 478 | 759 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,556 | 1,578 | 1,407 | 1,434 | 1,791 |
Depreciation & Amortization (Cash Flow) | 498 | 477 | 538 | 574 | 611 |
Income After Depreciation & Amortization | 1,058 | 1,101 | 869 | 860 | 1,180 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 119.40 | 124.90 | 137.10 | 136.50 | 138.50 |
Diluted EPS Before Non-Recurring Items | 6.40 | 7.88 | 8.85 | 6.15 | 7.13 |
Diluted Net EPS (GAAP) | 7.49 | 6.35 | 6.25 | 3.50 | 5.48 |
Fiscal Year end for Eastman Chemical Company falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 2,363.00 | 2,310.00 | 2,207.00 | 2,267.00 | 2,324.00 |
Cost Of Goods | 1,764.00 | 1,778.00 | 1,743.00 | 1,783.00 | 1,740.00 |
Gross Profit | 599.00 | 532.00 | 464.00 | 484.00 | 584.00 |
SG&A, R&D, and Dept/Amort Expenses | 240.00 | 261.00 | 263.00 | 230.00 | 245.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 359.00 | 271.00 | 201.00 | 254.00 | 339.00 |
Non-Operating Income | -30.00 | -18.00 | 364.00 | -2.00 | -22.00 |
Interest Expense | 50.00 | 49.00 | 52.00 | 57.00 | 54.00 |
Pretax Income | 287.00 | 214.00 | 425.00 | 199.00 | 269.00 |
Income Taxes | 56.00 | 49.00 | 114.00 | 20.00 | -3.00 |
Minority Interest | 1.00 | 0.00 | 1.00 | 1.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 231.00 | 165.00 | 311.00 | 179.00 | 272.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 230.00 | 165.00 | 310.00 | 178.00 | 272.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 118.60 | 118.20 | 118.70 | 119.00 | 119.60 |
Diluted EPS Before Non-Recurring Items | 2.15 | 1.61 | 1.31 | 1.47 | 1.99 |
Diluted Net EPS (GAAP) | 1.94 | 1.39 | 2.61 | 1.49 | 2.27 |